Stride, Inc. (LRN)

NYSE • Currently up 0.13 (+0.17%) in today's trading session

1 member of Congress has disclosed 1 trade in Stride, Inc. (LRN) via STOCK Act filings. The most recent disclosure was a sale by Lamar Smith on 21 October 2013. Aggregate disclosed activity totals roughly $8K in sales (midpoint estimates from bracketed disclosure amounts).

Stride, Inc. is currently trading at $75.00, positioned at 33% of its 52-week range ($60.61 – $103.67).

Want to automatically copy Pelosi trades?

Mirror Nancy Pelosi's portfolio with just one click on eToro.

Copy Trading does not amount to investment advice. The value of your investments may go up or down. Your capital is at risk.

Past Performance is not an indication of future results.

Current Price
$75.00
24h Change
+0.13 (+0.17%)
52 Week Range
$60.61–$103.67
View on NASDAQ

Stride, Inc. Price History and Technical Analysis

Congressional Trading Activity for LRN

Select to highlight on chart
1 transactions
Compliance: 0%
Lamar Smith21 Oct 20133 Dec 2014SaleStock$1,001 - $15,000N/A

Select transactions to view their annotations on the chart

Stock Overview

Market Data

Market Cap

$3.15B

Volume

1.43M

Beta

0.11

P/E Ratio

9.75

Fundamentals

EPS

$7.69

Div. Yield

-

Open

$73.65

Day Range

$73.01 – $76.28

Company Information

Sector
Consumer Defensive
Industry
Education & Training Services
Exchange
NYSE · USD
Country
US
CEO
Robert E. Knowling
IPO Date
2007-12-13

Stride, Inc. is an ed-tech company that specializes in providing a variety of online learning tools and services. The firm delivers personalized educational experiences to students, primarily from kindergarten through twelfth grade (K-12), across the...

Earnings

Next Report

Q4 2026

26 Jan

EPS Est.

$2.46

Rev. Est.

$635.8M

Days Until

78

Recent Quarters

Q3 202620 Oct
EPS$1.37
Beat 28.0%
Q2 20264 Aug
EPS$1.75
Beat 6.7%
Q1 202628 Apr
EPS$2.30
Beat 19.2%
Q4 202527 Jan
EPS$2.12
Beat 5.5%
Q3 202528 Oct
EPS$1.52
Beat 42.1%
Q2 20255 Aug
EPS$2.29
Beat 25.1%
Q1 202529 Apr
EPS$2.02
Miss 3.4%
Q4 202428 Jan
EPS$2.03
Beat 5.7%
Q3 202422 Oct
EPS$0.94
Beat 327.3%
Q2 20246 Aug
EPS$1.42
Beat 11.8%
Q1 202423 Apr
EPS$1.60
Beat 11.9%
Q4 202323 Jan
EPS$1.54
Beat 17.6%
Q3 202324 Oct
EPS$0.11
Beat 131.4%
Q2 202315 Aug
EPS$1.01
Beat 16.1%
Q1 202325 Apr
EPS$1.30
Beat 21.5%
Q4 202224 Jan
EPS$1.19
Beat 14.4%
Q3 202225 Oct
EPS$-0.54
Miss 315.4%
Q2 20229 Aug
EPS$0.66
Beat 4.8%
Q1 202219 Apr
EPS$1.02
Beat 21.4%
Q4 202125 Jan
EPS$1.00
Beat 29.9%
Q3 202119 Oct
EPS$-0.15
Miss 7.1%
Q2 202110 Aug
EPS$0.25
Beat 66.7%
Q1 202120 Apr
EPS$0.57
Beat 21.3%
Q4 202026 Jan
EPS$0.60
Beat 22.4%
Q3 202026 Oct
EPS$0.30
Beat 196.8%
Q2 202011 Aug
EPS$0.12
Beat 300.0%
Q1 202027 Apr
EPS$0.22
Beat 15.8%
Q4 201927 Jan
EPS$0.52
Beat 2.0%
Q3 201922 Oct
EPS$-0.25
Miss 31.6%
Q2 20196 Aug
EPS$0.08
Beat 300.0%
Q1 201923 Apr
EPS$0.44
Beat 18.9%
Q4 201822 Jan
EPS$0.59
Beat 5.4%
Q3 201823 Oct
EPS$-0.22
Beat 45.0%
Q2 20187 Aug
EPS$0.23
Beat 76.9%
Q1 201824 Apr
EPS$0.32
Miss 5.9%
Q4 201725 Jan
EPS$0.33
Beat 37.5%
Q3 201726 Oct
EPS$-0.21
Beat 41.7%
Q2 20178 Aug
EPS$0.09
Beat 80.0%
Q1 201727 Apr
EPS$0.42
Beat 68.0%
Q4 201626 Jan
EPS$0.30
Beat 11.1%
Q3 201626 Oct
EPS$-0.36
Miss 9.1%
Q2 20169 Aug
EPS$0.09
Miss 30.8%
Q1 201627 Apr
EPS$0.37
Beat 19.4%
Q4 201528 Jan
EPS$0.23
Beat 4.5%
Q3 201527 Oct
EPS$-0.34
Miss 13.3%
Q2 20154 Aug
EPS$0.18
Beat 80.0%
Q1 201528 Apr
EPS$0.45
Beat 21.6%
Q4 201429 Jan
EPS$0.33
Beat 13.8%
Q3 201430 Oct
EPS$-0.18
Beat 10.0%
Q2 201414 Aug
EPS$0.32
Beat 60.0%
Q1 201429 Apr
EPS$0.40
Beat 5.3%
Q4 20134 Feb
EPS$0.36
Beat 9.1%
Q3 20137 Nov
EPS$-0.13
Beat 0.0%
Q2 201329 Aug
EPS$0.06
Beat 100.0%
Q1 20133 May
EPS$0.31
Beat 34.8%
Q4 20125 Feb
EPS$0.24
Beat 9.1%
Q3 20129 Nov
EPS$0.11
Miss 21.4%
Q2 201212 Sept
EPS$0.05
Beat 266.7%
Q1 20128 May
EPS$0.18
Miss 14.3%
Q4 20117 Feb
EPS$0.11
Miss 57.7%
Q3 201115 Nov
EPS$0.17
Miss 26.1%
Q3 20117 Oct
EPS$-0.08
Q1 201110 May
EPS$0.16
Miss 23.8%
Q4 20109 Feb
EPS$0.23
Miss 4.2%
Q3 20109 Nov
EPS$0.07
Miss 75.9%
Q2 201013 Sept
EPS$-0.04
Beat 42.9%
Q1 201010 May
EPS$0.20
Beat 66.7%
Q4 20095 Feb
EPS$0.32
Beat 113.3%
Q3 20096 Nov
EPS$0.24
Beat 4.3%
Q2 20099 Sept
EPS$-0.02
Beat 0.0%
Q1 20098 May
EPS$0.12
Beat 9.1%
Q4 20089 Feb
EPS$0.12
Beat 20.0%
Q3 200813 Nov
EPS$0.20
Beat 17.6%
Q2 20088 Sept
EPS$0.61
Beat 1320.0%
Q1 20088 May
EPS$0.09
Beat 50.0%
Q4 200714 Feb
EPS$0.06
Beat 20.0%
Q2 200730 Sept
EPS$0.12
Q1 200730 Jun
EPS$-0.55
Q4 200631 Mar
EPS$0.70
Q3 200631 Dec
EPS$0.11
Q2 200630 Sept
EPS$0.11
Q1 200630 Jun
EPS$0.04
Q4 200531 Mar
EPS$0.04
Q3 200531 Dec
EPS$0.04
Q2 200530 Sept
EPS$0.04

1 politician traded within 30 days

No dividend data available for this stock.

No stock split data available for this stock.

Similar Stocks

Based on congressional trading patterns

Smart Recommendations
No similar stocks found
No congressional trading patterns available for recommendations

Frequently Asked Questions about LRN

Which members of Congress have traded LRN?
1 member of Congress has disclosed 1 trade in Stride, Inc. (LRN) under the STOCK Act: Lamar Smith.
When was LRN most recently disclosed by Congress?
The most recent LRN disclosure was a sale by Lamar Smith on 21 October 2013.
What is the total disclosed congressional trading volume for LRN?
Members of Congress have disclosed approximately $8K in LRN sales (midpoint estimate derived from the bracketed amount ranges used in STOCK Act filings).
How can I track new congressional trades in LRN?
This LRN page updates as soon as new STOCK Act disclosures are filed for Stride, Inc.. Every trade, politician, transaction date and amount range is surfaced above, typically within hours of the official filing appearing on the House or Senate disclosure portals.
Pelosi Tracker
© 2026 - All rights reserved. Powered by Vantara Labs
Pelosi Tracker is an independent, third-party platform. It is not affiliated with, endorsed by, or in any way associated with Nancy Pelosi, her office or her representatives, or with any other member of Congress. Any use of her name is solely for the purpose of discussing publicly available information.The information provided by Pelosi Tracker is for informational and educational purposes only and is not intended to serve as, nor should it be construed as, financial or investment advice. The data presented here is sourced from publicly available filings and records. While we strive for accuracy, timeliness, and completeness, we do not guarantee that all information is error-free or current.